Purple Biotech Ltd. (PPBT.TA)

ILA 6.9

(-4.17%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 195.8 Thousand - - 1 Million 1 Million 1 Million
Cost of Revenue 196 Thousand 120.00 55.00 58.00 80.00 -
Gross Profit -196.00 -120.00 -55.00 999.94 Thousand 999.92 Thousand 1 Million
Operating Expenses -22.46 Million 22.6 Million 17.93 Million 13.79 Million 8.75 Million 8.82 Million
Selling, General and Administrative Expenses 5.04 Million 6.28 Million 6.1 Million 6.3 Million 6.07 Million 4.45 Million
Research and Development Expenses 17.03 Million 16.32 Million 11.82 Million 7.48 Million 2.67 Million 5.26 Million
Other Expenses -44.54 Million - - -15.65 Million -216 Thousand -
Cost and Expenses -22.27 Million 22.6 Million 17.93 Million 13.79 Million 8.75 Million 8.82 Million
Operating Income 22.27 Million -22.6 Million -17.93 Million 12.61 Million -7.15 Million -7.82 Million
Interest Expense - 126 Thousand 212 Thousand 61 Thousand 181 Thousand 576 Thousand
Income Tax Expense - 877 Thousand 637 Thousand -15.66 Million 216 Thousand 207 Thousand
Earnings before Tax -19.97 Million -21.76 Million -17.82 Million -28.07 Million -5.89 Million -5.56 Million
Net Income -19.88 Thousand -21.66 Million -18.38 Million -27.99 Million -5.85 Million -5.2 Million
Earnings Per Share Basic -0.09 -0.12 -0.10 -0.24 -0.30 -0.37
Earnings Per Share Diluted -0.09 -0.12 -0.10 -0.24 -0.30 -0.37
Weighted Average Shares Outstanding 221.33 Million 180.81 Million 175.68 Million 115 Million 19.36 Million 14.2 Million
Weighted Average Shares Outstanding (Diluted) 221.33 Million 180.81 Million 175.68 Million 115 Million 19.36 Million 14.2 Million
Gross Margin -0.00 - - 1.00 1.00 1.00
EBIT Margin -113.51 - - -27.96 -7.64 -7.73
Profit Margin -0.10 - - -28.00 -5.85 -5.20
EBITDA -22.22 Million -21.43 Million -17.38 Million -28.41 Million -7.63 Million -7.72 Million
Earnings Before Tax Margin 113.74 - - 12.61 -7.16 -7.83

Income Statement Charts